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Anxiety and Risk of Incident Coronary Heart Disease
A Meta-Analysis
Annelieke M. Roest, MSC,* Elisabeth J. Martens, PHD,* Peter de Jonge, PHD,*† Johan Denollet, PHD*
Tilburg and Groningen, the Netherlands
Objectives The purpose of this study was to assess the association between anxiety and risk of coronary heart disease
(CHD).
Background Less research has focused on the association of anxiety with incident CHD in contrast to other negative emo-
tions, such as depression.
Methods A meta-analysis of references derived from PubMed, EMBASE, and PsycINFO (1980 to May 2009) was per-
formed without language restrictions. End points were cardiac death, myocardial infarction (MI), and cardiac
events. The authors selected prospective studies of (nonpsychiatric) cohorts of initially healthy persons in which
anxiety was assessed at baseline.
Results Twenty studies reporting on incident CHD comprised 249,846 persons with a mean follow-up period of 11.2
years. Anxious persons were at risk of CHD (hazard ratio [HR] random: 1.26; 95% confidence interval [CI]: 1.15
to 1.38; p  0.0001) and cardiac death (HR: 1.48; 95% CI: 1.14 to 1.92; p  0.003), independent of demo-
graphic variables, biological risk factors, and health behaviors. There was a nonsignificant trend for an associa-
tion between anxiety and nonfatal MI (HR: 1.43; 95% CI: 0.85 to 2.40; p  0.180). Subgroup analyses did not
show any significant differences regarding study characteristics, with significant associations for different types
of anxiety, short- and long-term follow-up, and both men and women.
Conclusions Anxiety seemed to be an independent risk factor for incident CHD and cardiac mortality. Future research should
examine the association between anxiety and CHD with valid and reliable anxiety measures and focus on the
mechanisms through which anxiety might affect CHD. (J Am Coll Cardiol 2010;56:38–46) © 2010 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.03.034o
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Tesearch has demonstrated an association between psycho-
ogical factors such as stress and both the development of
oronary heart disease (CHD) and CHD outcomes (1,2).
ost studies have focused on the role of depression, with
everal meta-analyses indicating that depression is an inde-
endent risk factor for the development of CHD in the
eneral population (3) as well as a prognostic risk factor in
HD patients (4). Although evidence suggests that anxiety
lso has an adverse impact on prognosis in CHD patients
ndependent of depression (5–8), the role of anxiety as an
tiological risk factor is less clear. Although several studies
uggest that anxiety might contribute to the development of
HD in initially healthy individuals (9) and found an effect
rom the *Center of Research on Psychology in Somatic Diseases, Tilburg University,
ilburg, the Netherlands; and the †Department of Psychiatry, University of Gro-
ingen, Groningen, the Netherlands. Dr. de Jonge is supported by a VIDI grant from
he Dutch Medical Research Council (grant 016.086.397). Dr. Denollet is supported
y a VICI grant from the Dutch Organization for Scientific Research (grant
53.04.004).s
Manuscript received November 4, 2009; revised manuscript received January 28,
010, accepted March 3, 2010.n cardiac death (10–12) or incident myocardial infarction
MI) (13,14), others have found no association (15,16).
Meta-analytic research might help to resolve these incon-
istencies, but to our knowledge, no recent meta-analysis
as yet been conducted on the association between anxiety
nd incident heart disease. Therefore, the present meta-
nalysis focuses on the impact of anxiety on the develop-
ent of CHD in initially healthy persons. The first objec-
ive of this study was to investigate the association of anxiety
See page 47
ith incident CHD independent of traditional cardiovas-
ular risk factors. The second objective was to examine
hether the associations between anxiety and incident
HD were different for MI versus cardiac mortality as
utcomes.
ethods
he aim was to assess the association between a comprehensive
et of common anxiety constructs (including anxiety, panic,
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June 29, 2010:38–46 Anxiety and Incident CHDhobia, post-traumatic stress, and worry) and incident CHD.
e identified all studies available by May 2009 on the
evelopment of CHD in anxious versus nonanxious persons.
ethods for systematic identification, appraisal, synthesis and
tatistical aggregation of information, and reporting of results
ere chosen according to predetermined methods (17,18).
iterature search. The electronic databases PubMed,
MBASE, and PsycINFO (1980 to May 2009) were searched
ith the following terms: “(community or cohort or healthy
ersons or risk) and (anxiety or post traumatic stress disorder or
ension or anxiety symptoms or anxiety disorder or panic or
anic attacks or phobic anxiety or phobia or worry) and
mortality or coronary mortality or myocardial infarction or
oronary heart disease or sudden cardiac death).” There were
o language restrictions, and both published and unpublished
ata were included. In addition, reference lists of included
tudies and review articles were checked to identify additional
tudies meeting selection criteria.
election. Two independent raters (A.R. and J.D.) identified
tudies meeting the following pre-specified inclusion criteria:
1. Studies were prospective in nature, following a (nonpsy-
chiatric) cohort of initially healthy persons over time.
2. At baseline, studies had to include at least 1 self-report or
interview-based assessment of anxiety symptoms or anx-
iety disorder (e.g., post-traumatic stress disorder, tension,
worry, phobic anxiety, panic, or generalized anxiety
disorder).
3. End points included cardiac mortality or MI.
tudies focusing explicitly on older persons (over 75 years of
ge) were excluded.
During the selection procedure, in case of disagreement
etween the 2 raters, the 4 investigators discussed the differ-
nce of opinion until consensus was reached. When study
amples included healthy persons combined with a small
umber of heart disease patients, these studies were included
hen the original study adjusted for the presence of medical
onditions (15,16,19–22). With regard to multiple reports on
he same dataset, only 1 article was included on the basis of the
nxiety measure, study sample, end point, and follow-up
eriod, preferring (in order of importance) general anxiety
easured with a reliable and valid measure, multiple cardiac
nd points (e.g., cardiac mortality and MI), larger sample sizes,
nd longer follow-up periods. With regard to the different
rticles reporting on the Normative Aging Study, the study of
ubzansky et al. (23) was included because this study reported
n general anxiety as measured with the Minnesota Multipha-
ic Personality Inventory and on nonfatal MI and cardiac
ortality. We included both studies of Haines et al. (10,24),
ecause they represented different outcomes. We retrieved the
ssociation between phobic anxiety and cardiac mortality from
he later study (given the longer follow-up period) (24) and the
ssociation between phobic anxiety and MI from the earlier
tudy (10). If necessary, the corresponding authors of the eli-
ible studies were asked to provide additional information. aInformation on sample size and
haracteristics (e.g., did the re-
earchers include specific inclu-
ion/exclusion criteria, such as
ex), anxiety assessment, end
oints, participation rate, percent-
ge lost to follow-up, follow-up
uration, bivariate and fully-
djusted relative risks and 95%
onfidence intervals (CIs), and variables used in multivariable
nalysis was abstracted and evaluated. We did not weigh the
ontribution of each study to the meta-analysis on the basis of
uality scoring, because there are no validated measures of
uality for observational studies and the use of subjective rating
cales might lead to bias (25).
nd points. We examined the association between anxiety
nd incident CHD. If a study reported on MI and cardiac
ortality separately, we included cardiac mortality as end point
23,26). We included the study by Haines et al. (24) reporting
n cardiac mortality. We focused on hard medical end points
nd, if possible, kept angina out of our analysis (23,27), because
nxiety might be associated with the report of symptoms of
hest pain without reflecting underlying CHD (27). One
ncluded study reported on a broader end point, namely
ardiovascular events (including cardiac death and nonfatal
I) (19). We also examined the associations between anxiety
nd nonfatal MI and cardiac mortality (including sudden
ardiac death and other cardiac death) separately.
uantitative data synthesis. Data from all studies were
ooled. We combined hazard ratios (HRs), relative risks, and
dds ratios from multivariable analyses. For 1 article we had to
ecalculate the CI (22), because the log values for lower and
pper limits were not symmetric. We suspected a relatively
arge heterogeneity in results, given that the included studies
iffered in anxiety types, anxiety measures, and sample charac-
eristics (e.g., sex). Therefore we used the random effects
ethod to generate a summary estimate of effect estimates and
ested the amount of heterogeneity with the Q test of homo-
eneity and the I2 test, which indicates the proportion of total
ariance explained by heterogeneity.
In 1 study the relative risk of anxiety predicting CHD was
xpressed relative to an SD increase in anxiety score (28). We
alculated a new relative risk and CI, on the basis of the
ssumption of normal distribution, assuming that 20% of the
ample experienced increased anxiety (mean anxiety prevalence
f other included studies).
If a study included various scales of the Crown Crisp Index
e.g., Haines et al. [10,24]), the phobic anxiety scale was
elected, because it was most representative of other studies
sing the Crown Crisp Index (11,26). If the association
etween anxiety and CHD was assessed separately for men and
omen, we included that study twice with sample sizes
ccording to the number of men and women in the study
22,28). In the studies from Eaker et al. (28,29), the tension
cale was used because it reflects psychological symptoms of
Abbreviations
and Acronyms
CHD  coronary heart
disease
CI  confidence interval
HR  hazard ratio
MI  myocardial infarctionnxiety, whereas the anxiety scale mainly reflects physiological
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Anxiety and Incident CHD June 29, 2010:38–46rousal (28) that might be confounded by underlying cardiac
isease.
We conducted a subgroup comparison between studies
ncluding all persons versus studies focusing on the contrast
etween high- versus low-anxiety subgroups.
If study outcomes were heterogeneous on the basis of the I2
est/Q test, the possible effects of anxiety type, follow-up
eriod, and study sample (healthy persons vs. healthy and heart
isease patients and men vs. women) were studied.
Differences in effect estimates between the subgroups were
ssessed by comparing the pooled effect estimates with chi-
quare analysis, comparing logarithms of these estimates. To
valuate the presence of publication bias, a funnel plot was
onstructed by plotting the effect measure against the inverse of
ts standard error. We used Egger’s test of the intercept, the
lassic fail-safe N, and Duval and Tweedie’s Trim and Fill test
o estimate the severity of publication bias. All analyses were
erformed with the program Comprehensive Meta-Analysis
ersion 2 (Biostat, Englewood, New Jersey).
dditional information by personal communication.
he author of 1 included study was contacted for further
nformation and supplied us with the multivariable HR of
nxiety predicting cardiovascular events (19).
esults
flow diagram of the literature search is shown in Figure 1.
he agreement rates (Cohen’s kappa) for the 2 steps in the
election procedure were 0.81 and 0.94, respectively, indicating
ery good consistency of judgment by raters (30). Twenty-one
tudies, published between 1987 and 2009, met selection
riteria of which the characteristics are shown in Tables 1 and
. Of these studies, 20 reported on incident CHD, 9 reported
n cardiac mortality, and 5 reported on nonfatal MI.
ncident CHD. Twenty studies that reported on incident
HD comprised 249,846 persons. Mean follow-up period was
1.2 years, with follow-up periods ranging from 2.0 to 20.9
ears. The mean age at baseline assessment ranged from 38 to
2 years. Eleven analyses reported on men, 7 reported on
omen, and 4 reported on a combined sample of men and
omen. Fourteen analyses (70%) showed a statistically signif-
cant univariable association between anxiety and CHD, and
0 (50%) were significant in multivariable analyses (Table 2).
The pooled HR for incident CHD (favoring cardiac death
n case of multiple end points) was 1.26 (95% CI: 1.15 to 1.38;
 0.0001) when pooling multivariable and bivariate HRs, in
ase no multivariable HR was reported in the original study
27,31) (Fig. 2).
ardiac mortality and MI. Nine of the 21 included studies
ocused on cardiac mortality as a separate end point. Five
tudies found a significant association between anxiety and
ardiac mortality (11,21,26,32,33), of which 3 remained sig-
ificant in multivariable analyses (11,32,33). The pooled mul-
ivariable HR for cardiac mortality was 1.48 (95% CI: 1.14 to
.92; p  0.003). The heterogeneity was lower than for
ncident CHD (Q  17.61; p  0.024; I2  54.57). bFive studies focused on nonfatal MI as a separate end point.
wo studies found a significant association between general
nxiety and MI (23,31), although 1 did not adjust for con-
ounders (31). The pooled HR for nonfatal MI was 1.43 (95%
I: 0.85 to 2.40; p  0.180). When excluding the article that
id not adjust for confounders (31), the HR decreased to 1.23
95% CI: 0.74 to 2.05; p  0.416). There was no significant
ifference between the impact of anxiety on cardiac death
ersus nonfatal MI (p  0.91).
ubgroup analyses. Studies that included all persons in their
nalyses had a smaller pooled HR (1.19; 95% CI: 1.07 to 1.33)
n comparison with studies focusing on the contrast between
igh- versus low-anxiety subgroups (HR: 1.39; 95% CI: 1.16
o 1.66), but this difference was not statistically significant (p
.15). There were no further differences for study sample,
nxiety type, and follow-up period.
A funnel plot of selected studies on the primary outcome
uggested the presence of publication bias. Egger’s test showed
significant asymmetry (p  0.0001). The Fail-Safe N shows
hat another 389 null-studies are needed for the p value to
xceed 0.05. According to the Trim and Fill test, the associa-
ion between anxiety and CHD remains significant after
mputing possible missing studies (HR: 1.16; 95% CI: 1.06 to
.28) (Fig. 3).
iscussion
his is the first meta-analysis focusing on the association of
nxiety with the incidence of CHD in initially healthy indi-
iduals. The results show an association between anxiety and
ncident CHD with a 26% increase in risk. Anxiety was also
pecifically associated with cardiac mortality, with anxious
ersons having a 48% increased risk of cardiac death. There
as a trend for an association between anxiety and incident
onfatal MI, but this association was based on only 5 studies.
ubgroup analyses did not show any significant differences
egarding study characteristics with significant associations for
ifferent types of anxiety, short- and long-term follow-up, and
oth men and women. Secondary analyses in the original
tudies, excluding heart disease patients at baseline, also did not
ffect the results (19,20).
Recently published studies using large databases demon-
trated a significant association between anxiety and MI
34) and panic disorder and CHD (35,36).
A strength of this meta-analysis is the adjustment for
ovariates in most of the individual studies that were included.
nly 2 studies did not adjust for covariates (27,31), of which 1
eported a significant association between anxiety and MI (31).
ll other studies adjusted for a variety of demographic vari-
bles, biological risk factors, and health behaviors. After ad-
ustment for these variables, the HRs decreased but still
emained significant.
It is important to compare the strength of the association
etween anxiety and incident CHD with other psychological
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June 29, 2010:38–46 Anxiety and Incident CHDonstructs. A recent meta-analysis showed that depression was
ssociated with a 46% increased risk of cardiovascular disease
37), and the impact of depression on cardiac death (55%
ncreased risk) was comparable to the impact of anxiety found
n the present meta-analysis. Five studies on anxiety and CHD
Figure 1 Flow-Chart of Literature Search
*Both reports of Haines et al. (10,24) were included: 1 with cardiac death (24), a
CHD  coronary heart disease; MI  myocardial infarction.djusted for depression in their analyses (20,23,32,38,39), and aassociations remained significant (20,23,32,38). In a study by
hillips et al. (21), subjects with both generalized anxiety
isorder and major depressive disorder were at greatest risk of
ubsequent cardiac death, suggesting that anxiety and depres-
ion might also interact synergistically to affect CHD. Anxiety
ith nonfatal myocardial infarction (MI) (10) as end point.nd 1 wnd depression have a moderate-to-strong correlation, and it is
Overview of Selected Studies Investigating the Association of Anxiety With Incident CHDTable 1 Overview of Selected Studies Investigating the Association of Anxiety With Incident CHD
First Author (Ref. #) n
Mean Age
(yrs)
Male
(%)
Nation, Year of
Baseline Assessment
Participation
(%)
Lost to
Follow-Up (%) Instrument Anxiety Type
Follow-Up
(yrs) End Points
Phillips et al. (21) 4,256 38 100 U.S., 1986 69 0 DIS Generalized anxiety
disorder
14.6 Cardiac mortality
Kubzansky et al. (38) 1,059 44 0 U.S., 1982 NA 23.6 NIMH DIS PTSD symptoms 14.0 Cardiac events*
Einvik et al. (19) 433 NA 100 Norway, 1997 72 0 HADS-A General 3.0 Cardiovascular events†
Denollet et al. (32) 5,073 50 0 the Netherlands, 1994 83 0 EDS
Anxiety subscale
General 10.0 Cardiac mortality
Mykletun et al. (15) 61,349 48 NA Norway, 1995 66 NA HADS-A General 4.4 Cardiac mortality
Smoller et al. (20) 3,369 66 0 U.S., 1997 NA 0.03 Questionnaire based
on DSM-IV
Panic attacks 5.3 Cardiac events‡
Gafarov et al. (31) 2,149 NA 100 Russia, 1984 NA NA STAI General 20.0 MI
Kubzansky et al. (23) 1,306 61 100 U.S., 1986 82.4 NA MMPI-2
Anxiety subscale
General 10.9 Nonfatal MI and
cardiac mortality
Thurston et al. (40) 6,265 NA 46 U.S., 1971 70 0 GWB-A General 15.1 Cardiac events§
Boyle et al. (39) 2,105 47 100 U.S., 1985 NA 3.0 MMPI-2 General 15.0 IHD
Albert et al. (26) 72,359 54 0 U.S., 1988 NA 2.0 CCI
Phobia index
Phobic 12.0 Nonfatal MI and
cardiac mortality
Eaker et al. (28) 3,682 49 48 U.S., 1984 NA 5 Tension and Symptoms
of Anxiety Scales
General 10.0 Cardiac events
Nicholson et al. (27) 5,449 NA 100 U.K., 1985 74 NA GHQ-30
Anxiety subscale
General 6.8 Cardiac events‡
Ringbäck Weitoft et al. (22) 34,511 43 50 Sweden, 1980 79–86 NA Single question General 5.0 IHD
Yasuda et al. (16) 817 72 39 Japan, 1991 92 2.8 GHQ-30
Anxiety subscale
General 7.5 Cardiac mortality
Haines et al. (24) 1,408 NA 100 U.K., 1972 80 NA CCI
Phobia index
Phobic 20.9 Cardiac mortality
Kawachi et al. (11) 33,999 NA 100 U.S., 1986 NA 4.0 CCI
Phobia index
Phobic 2.0 Nonfatal MI and
cardiac mortality
Vogt et al. (41) 2,573 NA 46 U.S., 1970 92 0 Bradburn Worries Index Worry 15.0 IHD
Eaker et al. (29) 749 NA 0 U.S., 1965 NA NA Tension and Symptoms
of Anxiety Scales
General 20.0 Cardiac events‡
Rosengren et al. (33) 6,935 NA 100 Sweden, 1970 76 NA Single question General 11.8 Cardiac events‡
Haines et al. (10) 1,342 NA 100 U.K., 1972 80 2.8 CCI
Phobia index
Phobic 6.7 Nonfatal MI
*Angina pectoris, nonfatal myocardial infarction (MI), fatal MI, and other cardiac death. †Cardiac death, nonfatal MI, percutaneous coronary intervention, coronary artery bypass graft, cerebral stroke, surgery on abdominal aortic aneurysm, and revascularization in peripheral
arterial disease. ‡Nonfatal MI and cardiac death. §MI, other acute and subacute ischemic heart disease, other forms of chronic ischemic heart disease. Nonfatal MI, coronary insufficiency, and cardiac death.
CCI  Crown-Crisp Index; CHD  coronary heart disease; DIS  Diagnostic Interview Schedule; DSM  Diagnostic Statistical Manual; EDS  Edinburgh Depression Scale; GHQ  General Health Questionnaire; GWB-A  General Well-Being Schedule anxiety subscale;
HADS-A Hospital Anxiety and Depression Scale, anxiety subscale; IHD ischemic heart disease; MMPIMinnesota Multiphasic Personality Inventory; NA not available; NIMH National Institute of Mental Health; PTSD post-traumatic stress disorder; STAI State-Trait
Anxiety Index.
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June 29, 2010:38–46 Anxiety and Incident CHDossible that anxiety and depression are both part of a larger
nd more stable psychological factor influencing heart disease,
ike negative affectivity (42,43). A recent meta-analysis focus-
ng on the association of anger and hostility with CHD found
verview of Bivariate and Multivariable Associations of Anxiety WiTable 2 Overview of Bivariate and Multivariable Associations o
First Author (Ref. #) Adjustment
HR/RR/OR
(95% CI)
Phillips et al. (21) Age 2.89 (1.59–5.23)* Age, place
consum
total ch
Kubzansky et al. (38) Age 3.21 (1.29–7.98)* Age, race/
history o
Einvik et al. (19) — 3.17 (1.28–7.82)* Age, previo
serum g
treatme
Denollet et al. (32) Age 2.74 (1.15–6.49)* Age, educa
physica
Mykletun et al. (15) Age and sex 1.10 (0.84–1.43) Age, sex, s
health-r
educatio
total ch
Smoller et al. (20) Age, race, income 1.92 (1.20–3.07)* Age, race,
requirin
depress
strenuo
history o
Gafarov et al. (31) — 2.70 (1.27–5.71)*
Kubzansky et al. (23) Age 2.11 (0.8–5.6) Age, BMI, s
of CHD,
Thurston et al. (40) Age and sex 1.56 (1.31–1.86)* Age, sex, m
alcohol
Boyle et al. (39) Age 1.18 (1.08–1.29)* Age, total
HDL, an
Albert et al. (26) Age 1.55 (1.16–2.08)* Age, smok
use, par
history o
Eaker et al. (28)
men
— NA Age, SBP,
HDL cho
Eaker et al. (28)
women
— NA Age, SBP,
HDL cho
Nicholson et al. (27) Age 1.28 (0.76–2.16) Age
Ringbäck Weitoft et al.
(22) men
Age 1,82 (1.35–2.45)* Age, smok
Ringbäck Weitoft et al.
(22) women
Age 1.28 (0.94–1.74) Age, smok
Yasuda et al. (16) — NA Age, sex, c
and ava
Haines et al. (24) — NA Age, smok
Kawachi et al. (11) Age 1.40 (0.83–2.37) Age, smok
hyperch
physica
Vogt et al. (41) — 2.34 (1.72–3.20)* Age, sex, s
smoking
Eaker et al. (29) NA NA Age, SBP,
cigarett
Rosengren et al. (33) — 1.6 (1.3–2.0)* Age, SBP,
occupat
registra
Haines et al. (10) — NA Age, smok
choleste
Statistically significant. †Hazard ratio (HR) received from author. ‡On the basis of own calculatio
BMI  body mass index; CABG  coronary artery bypass graft; CI  confidence interval; DBP 
TCA  percutaneous transluminal coronary angioplasty; SBP  systolic blood pressure; SES  s19% increased risk, but: 1) this association was no longer cignificant after adjusting for possible behavioral covariates
44); and 2) the association with CHD mortality was not
ignificant (44). This difference in anxiety and anger as poten-
ial predictors of cardiac death is of interest and calls for
ident CHDiety With Incident CHD
Adjustment
HR/RR/OR
(95% CI)
vice, ethnicity, marital status, smoking habit, alcohol
IQ at enlistment, household income in midlife, BMI,
ol, SBP, blood glucose, and somatic illness.
1.84 (0.98–3.45)
ty, smoking status, history of high blood pressure,
etes, alcohol use, education, income.
3.46 (1.35–8.90)*
diovascular disease, current smoking, level of
, diabetes, SBP, LDL cholesterol, alcohol use, BMI,
dality.
3.23 (1.26–8.27)*†
iving alone, hormone intake, smoking, alcohol,
ty, BMI, hypertension, diabetes, depressive symptoms.
2.77 (1.17–6.58)*
symptoms/diagnoses, physical impairment,
behavior (smoking, alcohol problems, physical activity),
vel and SES, physical measurement (BMI, DBP,
ol level).
0.89 (0.67–1.16)
e, BMI, alcohol, hormone use, high cholesterol level
ication, history of diabetes mellitus treatment, smoking,
story of atrial fibrillation, hypertension status, moderate to
vity for longer than 20 min 3 or more times a week, and
ABG, PTCA, or stroke.
4.20 (1.76–9.99)*
— 2.70 (1.27–5.71)*
g status, SBP and DBP, serum cholesterol, family history
l use, education.
2.11 (0.8–5.8)
status, race/ethnicity, smoking status, aerobic exercise,
BP, DBP, BMI, cholesterol, hypertension, diabetes status.
1.38 (1.15–1.66)*
terol, smoking status, hypertensive status, diabetes status, 1.15 (1.05–1.25)*
tus, BMI, alcohol intake, menopausal status and hormone
istory of MI, physical activity, aspirin use, valium use,
rtension, hypercholesterolemia, and diabetes.
1.18 (0.88–1.58)
rrent cigarette smoking, diabetes, and total cholesterol/
ol.
1.04 (1.01–1.08)*‡
rrent cigarette smoking, diabetes, and total cholesterol/
ol.
1.00 (0.95–1.05)‡
1.28 (0.76–2.16)
gstanding illness, education. 1.49 (1.14–1.94)*
gstanding illness, education. 1.04 (0.75–1.45)
conditions under treatment, regular physical activity,
y of close or casual neighbors.
1.84 (0.76–4.42)
I, fibrinogen, factor VII, SBP, cholesterol, social class. 1.29 (0.71–2.34)
cohol, BMI, history of hypertension, diabetes mellitus,
rolemia, parental history of MI before the age of 60 yrs,
ty.
1.24 (0.73–2.11)
orted health status, self-reported social class, cigarette
s, duration of health plan membership.
1.18 (0.85–1.63)
f the serum total cholesterol to HDL cholesterol, diabetes,
ing and BMI.
2.9 (1.3–6.8)*
cholesterol, smoking, BMI, diabetes, family history of MI,
lass, marital state, leisure time physical activity,
r alcohol abuse.
1.5 (1.2–1.9)*
bit, social class, shift (night or day), SBP, fibrinogen,
ctor VII activity.
1.26 (0.62–2.54)
c blood pressure; HDL  high-density lipoprotein; LDL  low-density lipoprotein; OR  odds ratio;
nomic status; other abbreviations as in Table 1.th Incf Anx
of ser
ption,
olester
ethnici
f diab
us car
lucose
nt mo
tion, l
l activi
omatic
elated
nal le
olester
incom
g med
ion, hi
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f MI, C
mokin
alcoho
arital
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choles
d BMI.
ing sta
ental h
f hype
BMI, cu
lester
BMI, cu
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ing, lon
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ing, BM
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Anxiety and Incident CHD June 29, 2010:38–46There are several potential mechanisms that might help to
xplain the adverse association between anxiety and CHD.
nxiety has been associated with progression of atherosclerosis
45), decreased heart rate variability (46), and risk of ventricular
rrhythmias (47,48). Research supports the risk of arrhythmias
articularly in the case of phobic anxiety, with studies showing
n association between phobic anxiety and sudden cardiac
eath but not with nonfatal MI (11,26). More research is
eeded focusing on these possible mechanisms and the impact
n different outcomes, particularly MI versus (sudden) cardiac
eath. Furthermore, anxiety is related to an unhealthy lifestyle
n patients at risk of CHD (49). In the present meta-analysis,
nhealthy lifestyles (e.g., physical inactivity, increased body
ass index, and smoking) were included as covariates, but they
ight also mediate the relationship between anxiety and
HD. This might indicate that the association between
nxiety and CHD might be larger than reported here.
Anxiety can be treated effectively with cognitive behavior
herapy and medications (e.g., benzodiazepines and selective
erotonin reuptake inhibitors) (50). Unfortunately, many pa-
ients do not receive adequate treatment (50). Besides the
mpact of anxiety on disability and decreased quality of life,
linicians should be aware of the risk of anxiety associated with
ncident heart disease. Future research needs to investigate
hether the treatment of anxiety has a significant beneficial
Figure 2 Anxiety and Risk of Incident CHD
Forest plot of individual studies investigating the association between anxiety andffect on the incidence or course of cardiac disease (51). Ctudy limitations. The results need to be considered in light
f the study limitations. One important limitation in conduct-
ng a meta-analysis is the inevitability of combining data from
tudies that are not equally designed. Study samples were
eterogeneous regarding age and sex, and follow-up duration
iffered substantially across studies. Furthermore, different
nxiety measures were included, some of which were not
xtensively validated. As a result, the heterogeneity in our
esults is substantial. Also, only 1 included article focused on an
nxiety disorder, namely generalized anxiety disorder (21). It is
mportant that studies use a valid and reliable anxiety measure,
nd more research is needed on the association of anxiety
isorders with heart disease development. However, the find-
ng of an association between anxiety and CHD was quite
onsistent across studies. Also, studies reporting on the Nor-
ative Aging Study showed comparable results for different
nxiety types, such as post-traumatic stress disorder (52) and
orry (13), suggesting that a broad variety of anxiety symptoms
nfluence incidence of CHD. Future research should focus on
he specific aspects of anxiety that contribute to cardiac
utcomes. Furthermore, almost all studies were conducted in
estern populations, which might limit the generalization of
he findings. Another limitation is that meta-analyses are
rone to publication bias. We found an indication for publi-
ation bias, suggesting that the association between anxiety and
nt coronary heart disease (CHD). CI  confidence interval.incideHD might be smaller than reported here. However, after
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June 29, 2010:38–46 Anxiety and Incident CHDdjusting for this possible bias, the results still show a reliable
ssociation of anxiety with CHD.
onclusions
nxiety was found to be an independent risk factor for the
ncidence of CHD and cardiac mortality in initially healthy
ndividuals. The strength of this association seemed to be
omewhat lower compared with the effect of depression but
learly higher than that of anger. Future research should
xamine the relationship between anxiety and CHD with valid
nd reliable anxiety measures and needs to focus on the
echanisms through which anxiety might affect the develop-
ent and onset of CHD.
eprint requests and correspondence: Dr. Johan Denollet,
oRPS, Department of Medical Psychology, Tilburg University,
.O. Box 90153, 5000 LE Tilburg, the Netherlands. E-mail:
.denollet@uvt.nl.
EFERENCES
1. Brotman DJ, Golden SH, Wittstein IS. The cardiovascular toll of
stress. Lancet 2007;370:1089–100.
2. Rosengren A, Hawken S, Ounpuu S, et al., INTERHEART Inves-
tigators. Association of psychosocial risk factors with risk of acute
myocardial infarction in 11119 cases and 13648 controls from 52
countries (the INTERHEART study): case-control study. Lancet
2004;364:953–62.
3. Wulsin LR, Singal BM. Do depressive symptoms increase the risk for
Figure 3 Funnel Plot of Selected Studies
Funnel plot depicting the relationship between effect size and standard error of efthe onset of coronary disease? A systematic quantitative review.
Psychosom Med 2003;65:201–10.4. Van Melle JP, De Jonge P, Spijkerman TA, et al. Prognostic
association of depression following myocardial infarction with mortal-
ity and cardiovascular events: a meta-analysis. Psychosom Med 2004;
66:814–22.
5. Rothenbacher D, Hahmann H, Wüst B, Koenig W, Brenner H.
Symptoms of anxiety and depression in patients with stable coronary
heart disease: prognostic value and consideration of pathogenetic links.
Eur J Cardiovasc Prev Rehabil 2007;14:547–54.
6. Shibeshi WA, Young-Xu Y, Blatt CM. Anxiety worsens prognosis in
patients with coronary artery disease. J Am Coll Cardiol 2007;49:
2021–7.
7. Strik JJMH, Denollet J, Lousberg R, Honig A. Comparing symptoms
of depression and anxiety as predictors of cardiac events and increased
health care consumption after myocardial infarction. J Am Coll
Cardiol 2003;42:1801–7.
8. Grace SL, Abbey SE, Irvine J, Shnek ZM, Stewart DE. Prospective
examination of anxiety persistence and its relationship to cardiac
symptoms and recurrent cardiac events. Pyschother Psychosom 2004;
73:344–52.
9. Kubzansky LD, Kawachi I. Anxiety and coronary heart disease: a
synthesis of epidemiological, psychological, and experimental evi-
dence. Ann Behav Med 1998;20:47–58.
0. Haines AP, Imeson JD, Meade TW. Phobic anxiety and ischaemic
heart disease. Br Med J 1987;295:297–9.
1. Kawachi I, Colditz GA, Ascherio A, et al. Prospective study of phobic
anxiety and risk of coronary heart disease in men. Circulation 1994;
89:1992–7.
2. Kawachi I, Sparrow D, Vokonas PS, Weiss ST. Symptoms of anxiety
and risk of coronary heart disease. The Normative Aging Study.
Circulation 1994;90:2225–9.
3. Kubzansky LD, Kawachi I, Spiro A III, Weiss ST, Vokonas PS,
Sparrow D. Is worrying bad for your heart? A prospective study of
worry and coronary heart disease in the Normative Aging Study.
Circulation 1997;95:818–24.
4. Shen BJ, Avivi YE, Todaro JF, et al. Anxiety characteristics indepen-
dently and prospectively predict myocardial infarction in men. J Am
th possible missing studies imputed.fect wiColl Cardiol 2008;51:113–9.
11
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
5
5
5
K
46 Roest et al. JACC Vol. 56, No. 1, 2010
Anxiety and Incident CHD June 29, 2010:38–465. Mykletun A, Bjerkeset O, Dewey M, Prince M, Overland S, Stewart
R. Anxiety, depression, and cause-specific mortality: the HUNT study.
Psychosom Med 2007;69:323–31.
6. Yasuda N, Mino Y, Koda S, Ohara H. The differential influence of
distinct clusters of psychiatric symptoms, as assessed by the General
Health Questionnaire, on cause of death in older persons living in a
rural community of Japan. J Am Geriatr Soc 2002;50:313–20.
7. Stroup DF, Berlin JA, Morton SC et al., for the Meta-analysis Of
Observational Studies in Epidemiology (MOOSE) Group. Meta-
analysis of observational studies in epidemiology: a proposal for
reporting. JAMA 2000;283:2008–12.
8. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for
reporting systematic reviews and meta-analyses of studies that evaluate
health care interventions: explanation and elaboration. Ann Intern
Med 2009;151:W65–94.
9. Einvik G, Ekeberg O, Klemsdal TO, Sandvik L, Hjerkinn EM.
Physical distress is associated with cardiovascular events in a high risk
population of elderly men. BMC Cardiovasc Disord 2009;9:14.
0. Smoller JW, Pollack MH, Wassertheil-Smoller S, et al. Panic attacks
and risk of incident cardiovascular events among postmenopausal
women in the Women’s Health Initiative Observational Study. Arch
Gen Psychiatry 2007;64:1153–60.
1. Phillips AC, Batty GD, Gale CR, et al. Generalized anxiety disorder,
major depressive disorder, and their comorbidity as predictors of
all-cause and cardiovascular mortality: the Vietnam experience study.
Psychosom Med 2009;71:395–403.
2. Ringbäck Weitoft G, Rosén M. Is perceived nervousness and anxiety
a predictor of premature mortality and severe morbidity? Longitudinal
follow up of the Swedish survey of living conditions. J Epidemiol
Community Health 2005;59:794–8.
3. Kubzansky LD, Cole SR, Kawachi I, Vokonas P, Sparrow D. Shared
and unique contributions of anger, anxiety, and depression to coronary
heart disease: a prospective study in the normative aging study. Ann
Behav Med 2006;31:21–9.
4. Haines A, Cooper J, Meade TW. Psychological characteristics and
fatal ischaemic heart disease. Heart 2001;85:385–9.
5. Pettiti DB. Of babies and bathwater. Am J Epidemiol 1994;140:
779 – 82.
6. Albert CM, Chae CU, Rexrode KM, Manson JE, Kawachi I. Phobic
anxiety and risk of coronary heart disease and sudden cardiac death
among women. Circulation 2005;111:480–7.
7. Nicholson A, Fuhrer R, Marmot M. Psychological distress as a
predictor of CHD events in men: the effect of persistence and
components of risk. Psychosom Med 2005;67:522–30.
8. Eaker ED, Sullivan LM, Kelly-Hayes M, D’Agostino RB Sr., Ben-
jamin EJ. Tension and anxiety and the prediction of the 10-year
incidence of coronary heart disease, atrial fibrillation, and total mor-
tality: the Framingham Offspring Study. Psychosom Med 2005;67:
692–6.
9. Eaker ED, Pinsky J, Castelli WP. Myocardial infarction and
coronary death among women: psychosocial predictors from a
20-year follow-up of women in the Framingham Study. Am J
Epidemiol 1992;135:854 – 64.
0. Brennan P, Silman A. Statistical methods for assessing observer
variability in clinical measures. BMJ 1992;304:1491–4.
1. Gafarov VV, Gromova HA, Gagulin IV, Ekimova YC, Santrapinskiy
DK. Arterial hypertension, myocardial infarction and stroke: risk of
development and psychosocial factors. Alaska Med 2007;49:117–9.
2. Denollet J, Maas K, Knottnerus A, Keyzer JJ, Pop VJ. Anxiety
predicted premature all-cause and cardiovascular death in a 10-year
follow-up of middle-aged women. J Clin Epidemiol 2009;62:452–6.
3. Rosengren A, Tibblin G, Wilhelmsen L. Self-perceived psychological
stress and incidence of coronary artery disease in middle-aged men.
Am J Cardiol 1991;68:1171–5. m4. Jakobsen AH, Foldager L, Parker G, Munk-Jørgensen P. Quantifying
links between acute myocardial infarction and depression, anxiety and
schizophrenia using case register databases. J Affect Disord 2008;109:
177–81.
5. Gomez-Caminero A, Blumenthal WA, Russo LJ, Brown RR,
Castilla-Puentes R. Does panic disorder increase the risk of coronary
heart disease? A cohort study of a national managed care database.
Psychosom Med 2005;67:688–91.
6. Walters K, Rait G, Petersen I, Williams R, Nazareth I. Panic disorder
and risk of new onset coronary heart disease, acute myocardial
infarction, and cardiac mortality: cohort study using the general
practice research database. Eur Heart J 2008;29:2981–8.
7. Van der Kooy K, van Hout H, Marwijk H, Marten H, Stehouwer C,
Beekman A. Depression and the risk for cardiovascular diseases:
systematic review and meta analysis. Int J Geriatr Psychiatry 2007;22:
613–26.
8. Kubzansky LD, Koenen KC, Jones C, Eaton WW. A prospective
study of posttraumatic stress disorder symptoms and coronary heart
disease in women. Health Psychol 2009;28:125–30.
9. Boyle SH, Michalek JE, Suarez EC. Covariation of psychological
attributes and incident coronary heart disease in U.S. Air Force
veterans of the Vietnam war. Psychosom Med 2006;68:844–50.
0. Thurston RC, Kubzansky LD, Kawachi I, Berkman LF. Do depres-
sion and anxiety mediate the link between educational attainment and
CHD? Psychosom Med 2006;68:25–32.
1. Vogt T, Pope C, Mullooly J, Hollis J. Mental health status as a
predictor of morbidity and mortality: a 15-year follow-up of members
of a health maintenance organization. Am J Public Health 1994;84:
227–31.
2. Suls J, Bunde J. Anger, anxiety, and depression as risk factors for
cardiovascular disease: the problems and implications of overlapping
affective dispositions. Psychol Bull 2005;131:260–300.
3. Denollet J. Depression, anxiety and trait negative affect as predictors of
cardiac events: ten years after. Psychosom Med 2008;70:949–51.
4. Chida Y, Steptoe A. The association of anger and hostility with future
coronary heart disease. J Am Coll Cardiol 2009;53:936–46.
5. Paterniti S, Zureik M, Ducimetière P, Touboul PJ, Fève JM, Alpéro-
vitch A. Sustained anxiety and 4-year progression of carotid athero-
sclerosis. Arterioscler Thromb Vasc Biol 2001;21:136–41.
6. Martens EJ, Nyklı´cek I, Szsabo´ BM, Kupper N. Depression and
anxiety as predictors of heart rate variability after myocardial infarc-
tion. Psychol Med 2008;38:375–83.
7. Van den Broek KC, Nyklı´cek I, van der Voort PH, Alings M, Meijer
A, Denollet J. Risk of ventricular arrhythmia after implantable
defibrillator treatment in anxious Type D patients. J Am Coll Cardiol
2009;54:531–7.
8. Watkins LL, Blumenthal JA, Davidson JR, Babyak MA, McCants
CB Jr., Sketh MH Jr. Phobic anxiety, depression, and risk of
ventricular arrhythmias in patients with coronary heart disease. Psy-
chosom Med 2006;68:651–6.
9. Bonnet F, Irving K, Terra JL, Nony P, Berthezène F, Moulin P.
Anxiety and depression are associated with unhealthy lifestyle in
patients at risk of cardiovascular disease. Atherosclerosis 2005;178:
339–44.
0. Davidson JR. First-line pharmacotherapy approaches for generalized
anxiety disorder. J Clin Psychiatry 2009;70:25–31.
1. Janeway D. An integrated approach to the diagnosis and treatment of
anxiety within the practice of cardiology. Cardiol Rev 2009;17:36–43.
2. Kubzansky LD, Koenen KC, Spiro A III, Vokonas PS, Sparrow D.
Prospective study of posttraumatic stress disorder symptoms and
coronary heart disease in the Normative Aging Study. Arch Gen
Psychiatry 2007;64:109–16.
ey Words: anxiety y cardiac mortality y coronary heart disease y
eta-analysis y myocardial infarction y risk.
